FDA Import Refusal 1FX-1596768-0/60002/1 — Glaxosmithkline Pharmaceuticals
The FDA refused shipment 1FX-1596768-0/60002/1 from Glaxosmithkline Pharmaceuticals (India) on Jul 21, 2026. The refused product falls under Drugs and Biologics — BETAMETHASONE SODIUM PHOSPHATE (GLUCOCORTICOID). Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jul 21, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 64LCA07 BETAMETHASONE SODIUM PHOSPHATE (GLUCOCORTICOID)
- Charges
- 118,75